Government must have compulsive licensing for essential drugs : Chairman, Cipla Farhat Nasim8 March 2019 9:30 AM ISTCipla Chairman, Y K Hamied said that many drugs which are not covered under patent should be made in India which is not happening at present, citing...
Cipla to launch Cinacalcet Hydrochloride tablets, a generic version of Sensipar Farhat Nasim7 March 2019 9:30 AM ISTCipla said, its cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg) is generic therapeutic equivalent version of Sensipar, a...
Cipla to acquire 11.71 percent stake in Wellthy Therapeutics Garima20 Feb 2019 2:55 PM ISTNew Delhi: Drug major Cipla Monday said it has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics. Golden cross Pharma, a...
NPPA fixes retail price of 68 drug formulations, check out details Medical Dialogues Bureau3 Nov 2018 11:14 AM ISTSome of the formulations whose price has been fixed by NPPA include Clarithromycin for Oral Suspension (CIPLA), Baclofen Oral Solution ( Sun Pharma),...
Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs Ruby Khatun Khatun8 Sept 2018 6:13 PM ISTThe 15 FDCs include those of big brands like Abbott Healthcare's Phensydyl, Paras Pharmaceutical's D-Cold Tablet, Alkem's Sumo, Franco-Indian...
Cipla launches Innoventia - To invest upto 15 million dollar in disruptive healthcare idea Ruby Khatun Khatun5 Jun 2018 3:37 PM ISTHurry up!!! Last date to apply is 17th June 2018!!If you have a groundbreaking Idea in healthcare to meet the unmet needs of patients then INNOVENTIA...
Cipla launches 2 digital education platforms-Ciplamed and Breathefree Ruby Khatun Khatun14 Dec 2017 11:00 AM ISTMumbai: In continuation to its commitment to patient-centricity and digitization, Cipla announces the launch of two digital assets, one aimed at...
Cipla gets WHO approval to sell TB preventing drug in HIV patients Ruby Khatun Khatun1 Dec 2017 2:40 PM ISTNew Delhi: Drug major Cipla said it has received approval from the World Health Organisation (WHO) for Q-TIB, a combination drug indicated to help...
Cipla gets USFDA nod for generic version of Renvela tablets supriya kashyap kashyap28 Oct 2017 9:18 AM ISTNew Delhi: Drug major Cipla said its subsidiary InvaGen Pharmaceuticals Inc has received final approval from the US health regulator for Sevelamer...
VPS Healthcare sets aside Rs 1,000 crore for investing in Indian Hospital Space Ruby Khatun Khatun20 Oct 2017 10:35 AM ISTMUMBAI: The son-in-law of the Lulu Group founder MA Yusuf Ali and founder of VPS Healthcare Group, Dr Shamsheer Vayalil, is reported to have created a...
DCGI grants limited approval to market Stempeucel® product for treating Critical Limb Ischemia due to Buerger's disease Geeta Sharma Sharma4 Jun 2016 1:21 PM ISTStempeutics Research, a group company of Manipal Education & Medical Group and a joint venture with Cipla Group, announced today that the Drugs...
Indian Pharma companies biggest violators of USFDA integrity norms Geeta Sharma Sharma7 May 2016 3:35 PM IST Mumbai:Sixty percent of reported data integrity violations in the records of US regulator since 2011 are against drug manufacturing units in...
